Crestline Investors is an institutional alternative investment management firm founded in 1997 and based in Fort Worth, Texas. It specializes in credit and opportunistic investments, including direct lending to lower-middle and middle-market companies, fund liquidity solutions, real estate, and derivative solutions.
Average disclosed round size is $122.4M (across 13 rounds with reported amounts).
Portfolio
13
Fund Size
—
Top Stage
Unknown
Last 12 Mo
0
Team
Andrey Panna
Senior Managing Director, Europe
Camille Sassman, CPA
Senior Managing Director, Chief Financial Officer
Mr. Aingorn
Senior Managing Director, Head of Liquid Credit
Mr. Bavin
Senior Managing Director, Co-Head of Client Partnership Group
Mr. Blewitt
Senior Managing Director, Head of Human Resources
Mr. Choy
Senior Managing Director
Mr. Christon
Senior Managing Director
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Constrafor | Series A | $264M | Nov 2024 |
 Upperline Health | Unknown | $58.4M | Jun 2023 |
 Sumup | Growth | $624M | Jun 2022 |
 Actifio, Inc. | Bridge | $100M | Aug 2018 |
 Vapotherm | Unknown | $30M | Jan 2016 |
 Vapotherm | Ipo | $56M | Jan 2016 |
 Juno Therapeutics | Series A | $176M | Apr 2014 |
| Actifio, Inc. | Bridge | $100M | Jan 2014 |
 Urgent Team | Series C | $18M | — |
| LLeading Pharma | Growth | $40M | — |
| NNapier AI | Unknown | — | — |
| CCredent Wealth Management | Unknown | $50M | — |
 SpringCM | Series A | $25M | — |
| CClinipace Worldwide | Unknown | $50M | — |
Top Co-Investors
Last updated: 20 October 2026